{"schema_version":"secwatch.filing_event.v1","accession":"0001411690-25-000005","form_type":"8-K","ticker":"BNGO","cik":"0001411690","company_name":"Bionano Genomics, Inc.","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.560216+00:00","generated_at":"2026-05-27T23:53:27.097750+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bionano Genomics stockholders approve reverse stock split (1:25-1:75) and warrant share issuance","bullets":["At Jan 15 special meeting, stockholders approved issuance of up to 19,762,226 shares upon exercise of Series C/D warrants.","Proposal 2 approved reverse stock split at ratio between 1-for-25 and 1-for-75, with exact ratio to be set by Board.","Approvals required for Nasdaq listing compliance and to maintain stock price above minimum bid.","Votes: Proposal 1 – 7.1M for, 3.3M against, 6.7M abstain, 25.3M broker non-votes.","Votes: Proposal 2 – 29.0M for, 12.8M against, 0.6M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001411690-25-000005","json":"https://secwatch.observer/filing/0001411690-25-000005.json","markdown":"https://secwatch.observer/filing/0001411690-25-000005.md","text":"https://secwatch.observer/filing/0001411690-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000005/0001411690-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411690/000141169025000005/bngo-20250115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T23:53:27.097750+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0000943374-26-000219","ticker":"DCOM","company_name":"Dime Community Bancshares, Inc. /NY/","filed_at":"2026-06-01T20:02:33+00:00","headline":"Dime Commercial Bancshares name change effective; three executives amend employment agreements","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000219","json":"https://secwatch.observer/filing/0000943374-26-000219.json","markdown":"https://secwatch.observer/filing/0000943374-26-000219.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/form8k_052826.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249857","ticker":"AIRJ","company_name":"AirJoule Technologies Corp.","filed_at":"2026-06-01T12:34:22+00:00","headline":"AirJoule Technologies raises $15M in registered direct offering at $4.10/share","event_type":"other_material","sec_items":["1.01","5.07","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249857","json":"https://secwatch.observer/filing/0001193125-26-249857.json","markdown":"https://secwatch.observer/filing/0001193125-26-249857.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855474/000119312526249857/0001193125-26-249857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855474/000119312526249857/airj-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001021771-26-000084","ticker":"BRTX","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-05-29T21:07:05+00:00","headline":"BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-26-000084","json":"https://secwatch.observer/filing/0001021771-26-000084.json","markdown":"https://secwatch.observer/filing/0001021771-26-000084.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/0001021771-26-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000084/brtx-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039233","ticker":"SKYE","company_name":"Skye Bioscience, Inc.","filed_at":"2026-05-29T20:54:45+00:00","headline":"Skye Bioscience stockholders approve 3x increase in authorized common shares to 300M","event_type":"other_material","sec_items":["5.03","5.07","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039233","json":"https://secwatch.observer/filing/0001628280-26-039233.json","markdown":"https://secwatch.observer/filing/0001628280-26-039233.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026039233/0001628280-26-039233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000162828026039233/skye-20260526.htm"},"side_by_side_evidence":null},{"accession":"0001679688-26-000062","ticker":"DBRG","company_name":"DigitalBridge Group, Inc.","filed_at":"2026-05-29T20:49:53+00:00","headline":"DigitalBridge shareholders approve 6M share increase to equity plan; 2.36M shares issued for OP unit redemption","event_type":"other_material","sec_items":["3.02","5.02","5.07","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001679688-26-000062","json":"https://secwatch.observer/filing/0001679688-26-000062.json","markdown":"https://secwatch.observer/filing/0001679688-26-000062.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1679688/000167968826000062/0001679688-26-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1679688/000167968826000062/dbrg-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026364","ticker":"ENVB","company_name":"Enveric Biosciences, Inc.","filed_at":"2026-05-29T20:13:38+00:00","headline":"Enveric shareholders approve reverse stock split, reject increase in authorized shares","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 5.07","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026364","json":"https://secwatch.observer/filing/0001493152-26-026364.json","markdown":"https://secwatch.observer/filing/0001493152-26-026364.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/0001493152-26-026364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001750155-26-000080","ticker":"CWBHF","company_name":"Charlotte's Web Holdings, Inc.","filed_at":"2026-06-01T21:13:23+00:00","headline":"Charlotte's Web appoints BAT GC to board, closes debt conversion & US$10M investment","event_type":"other_material","sec_items":["5.02","5.07","8.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 5.07","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001750155-26-000080","json":"https://secwatch.observer/filing/0001750155-26-000080.json","markdown":"https://secwatch.observer/filing/0001750155-26-000080.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/0001750155-26-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750155/000175015526000080/cweb-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251659","ticker":"MPT","company_name":"MEDICAL PROPERTIES TRUST INC","filed_at":"2026-06-01T20:55:09+00:00","headline":"MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition","event_type":"other_material","sec_items":["5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.15,"match_reasons":["same SEC item: 5.07","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251659","json":"https://secwatch.observer/filing/0001193125-26-251659.json","markdown":"https://secwatch.observer/filing/0001193125-26-251659.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1287865/000119312526251659/0001193125-26-251659-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1287865/000119312526251659/mpt-20260528.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}